<DOC>
	<DOCNO>NCT02288754</DOCNO>
	<brief_summary>The aim study employ genomic detection methodology measure relative amount tumor nucleic acid blood cancer patient diagnose metastatic disease either commencing , currently undergo complete cytotoxic chemotherapy treatment . More generally , approach allow u develop quantitative measure therapy efficacy via count relative change tumor molecule course treatment .</brief_summary>
	<brief_title>Detection Tumor DNA Blood Samples From Cancer Patients</brief_title>
	<detailed_description />
	<criteria>Age 18 year old Have metastatic disease primary cancer locate bladder , ovary , skin , lung , colon , prostate breast Have sample primary tumor formalinfixed , paraffin embed tissue block Undergoing undergone treatment cancer Able understand grant inform consent Able blood drawn Unable grant inform consent comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>DNA Tumors</keyword>
</DOC>